ResearcherMayo Clinic in ArizonaActive in the last 2 years

Patricia G Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0910-6701; OpenAlex author ID A5080947125. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

The Financial Burden of Pancreatic Enzyme Replacement Therapy for Patients With Resected Pancreatic Cancer. Co-author DOI 10.1002/jso.70361 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhi Ven Fong · 1 shared paper, 2026 · strength 0.29
- Paper The Financial Burden of Pancreatic Enzyme Replacement Therapy for Patients With Resected Pancreatic Cancer. DOI 10.1002/jso.70361 ↗
Nabil Wasif · 1 shared paper, 2026 · strength 0.29
- Paper The Financial Burden of Pancreatic Enzyme Replacement Therapy for Patients With Resected Pancreatic Cancer. DOI 10.1002/jso.70361 ↗
Rahul Pannala · 1 shared paper, 2026 · strength 0.29
- Paper The Financial Burden of Pancreatic Enzyme Replacement Therapy for Patients With Resected Pancreatic Cancer. DOI 10.1002/jso.70361 ↗
Yu-Hui H. Chang · 1 shared paper, 2026 · strength 0.29
- Paper The Financial Burden of Pancreatic Enzyme Replacement Therapy for Patients With Resected Pancreatic Cancer. DOI 10.1002/jso.70361 ↗
Chee‐Chee Stucky · 1 shared paper, 2026 · strength 0.29
- Paper The Financial Burden of Pancreatic Enzyme Replacement Therapy for Patients With Resected Pancreatic Cancer. DOI 10.1002/jso.70361 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.